Hara Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75M Sell
9,705
-251
-3% -$93.1K 1.98% 13
2026
Q1
$2.91M Buy
9,956
+92
+0.9% +$30.2K 1.45% 21
2025
Q4
$3.46M Sell
9,864
-620
-6% -$210K 1.92% 12
2025
Q3
$3.39M Buy
+10,484
New +$3.26M 2% 11

Other funds holding ELV

Hara Capital's ELV Position: Q2 2026 in Review

Hara Capital reduced its Elevance Health (ELV) stake by 2.5% in Q2 2026, selling an estimated $93.1K and leaving 9,705 shares worth $3.75M. The position accounts for 1.98% of the portfolio, ranked #13.

Hara Capital first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Hara Capital held 9,705 shares of Elevance Health worth $3.75M as of Q2 2026.
  • Hara Capital sold 251 Elevance Health shares in Q2 2026, an estimated $93.1K.
  • Elevance Health made up 1.98% of Hara Capital's portfolio in Q2 2026, its #13 holding.
  • Hara Capital first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.